Switching to a fixed-ratio combination of insulin degludec/liraglutide (IDegLira) is associated with improved glycaemic control in a real-world population with type 2 diabetes mellitus in the United Arab Emirates: Results from the multicentre, prospective INTENSIFY study-Reference-Cited by-同舟云学术

Switching to a fixed-ratio combination of insulin degludec/liraglutide (IDegLira) is associated with improved glycaemic control in a real-world population with type 2 diabetes mellitus in the United Arab Emirates: Results from the multicentre, prospective INTENSIFY study

Published:2023-02 Issue: Volume:196 Page:110183
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Abusnana Salah,Al Awadi Fatheya,Aly Hazem,Bashier Alaaeldin,Kumar Dhanwal Dinesh,Halasa Tariq,Jallo Mahir,Medina Johan,Singhal Sagar

Funder

Novo Nordisk

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference38 articles.

1. Clinical considerations when initiating and titrating insulin degludec/liraglutide (IDegLira) in people with type 2 diabetes;Harris;Drugs,2020

2. Clinical effectiveness of liraglutide in type 2 diabetes treatment in the real-world setting: a systematic literature review;Ostawal;Diabetes Ther,2016

3. American Diabetes Association. 6. Glycemic targets: standards of medical care in diabetes-2021. Diabetes Care 2021;44(Suppl. 1):S73–84. doi: 10.2337/dc21-S006.

4. 10-year follow-up of intensive glucose control in type 2 diabetes;Holman;N Engl J Med,2008

5. Moreira RO, Cobas R, Lopes Assis Coelho RC. Combination of basal insulin and GLP-1 receptor agonist: is this the end of basal insulin alone in the treatment of type 2 diabetes?. Diabetol Metab Syndr 2018;10:26.https://doi.org/10.1186/s13098-018-0327-4.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and Safety of Add-on Once-Daily Liraglutide (1.2 mg) in Type 2 Diabetes Patients with Obesity: Data from a Real-World Cohort of Iraqi Patients;Clinical Diabetology;2024-06-30

2. IDegLira for the real‐world treatment of type 2 diabetes in Italy. Final results from the REX observational study;Diabetes, Obesity and Metabolism;2024-02-08

3. Insulin degludec/liraglutide;Reactions Weekly;2023-03-04